Over the last month, Norman Hames has reported 5 Sell trades on RDNT for a total of $164.2k. In addition to Norman Hames, one other RDNT executive reported Sell trades in the last month.
Based on Radnet`s latest earnings report from June 30, the company posted quarterly revenue of $204.3M and quarterly net profit of $3.4M. In comparison, last year the company earned revenue of $179.1M and had a net profit of $5.14M. RDNT’s market cap is $263.7M and the company has a P/E ratio of 34.5%. The company has a one year high of $10.35 and a one year low of $5.80.
Looking at blogger coverage of RDNT, there is a 100% Bullish tendency on the stock, in relation to a 65% average bullish tendency within the Healthcare sector.
Over the last 3 months, the insider sentiment on Radnet has been negative based on 59 corporate insider transactions. This sentiment is lower than the average sector sentiment of insiders.
RadNet Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, and among others.